Pulse Biosciences, Inc. 8-K Report: Key Insights & Filing Details

Here are the key insights extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Pulse Biosciences, Inc.
- CIK Number: 0001625101
- Central Index Key (SEC): 001-37744
- EIN: 46-5696597
- Address: 601 Brickell Key Drive, Suite 1080, Miami, FL 33131
- Phone Number: 510-906-4600
- Filing Details:
- Filing Type: 8-K (a form used to report major events that shareholders should know about)
- Filing Date: December 23, 2024
- Stock Information:
- Common Stock Ticker Symbol: PLSE
- Exchange: NASDAQ
- Reporting Period:
- Start Date: December 23, 2024
- End Date: December 23, 2024
- XBRL Information:
- The report is structured in XBRL format, indicating it is intended for digital filing and analysis.
This information provides a snapshot of Pulse Biosciences, Inc.'s SEC filing, which is crucial for investors, analysts, and stakeholders to assess the company's current status and any significant events reported on that date.